Federal Register / Vol. 88, No. 217 / Monday, November 13, 2023 / Notices 77595 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Notice of Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Advisory Committee to 

the Director, National Institutes of 

Health. 

This will be a hybrid meeting held inperson and virtually and will be open to 

the public as indicated below. Given the 

capacity constraints of the venue, the 

public is strongly encouraged to attend 

virtually via NIH videocast. Individuals 

who plan to attend in-person or view 

the virtual meeting and need special 

assistance or other reasonable 

accommodations, should notify the 

Contact Person listed below in advance 

of the meeting. The meeting can be 

accessed from the NIH Videocast at the 

following link: https://

videocast.nih.gov/. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Advisory Committee 

to the Director, National Institutes of Health. 

Date: December 14, 2023. 

Time: 9:00 a.m. to 4:45 p.m. 

Agenda: Performing the Duties of the NIH 

Director’s Report; NIH Public Access Plan; 

Cancer Moonshot; Addressing the Mental 

Health Crisis through Research; Addressing 

the Public Health Threat of Post-Acute 

Sequelae of SARS CoV–2 Infection (PASC)— 

NIH RECOVER Initiative: Briefing for the 

Advisory Council to the Director (ACD); The 

Foundation for the National Institutes of 

Health (FNIH); Other Business of the 

Committee. 

Date: December 15, 2023. 

Time: 9:00 a.m. to 2:45 p.m. 

Agenda: HeLA Genome Data Access 

Working Group: Data Access Requests; NIHwide Collaborative Initiative on Climate 

Change and Health; Clinical Trial 

Stewardship; Accessibility Update; Update 

from the ACD Working Group on Catalyzing 

the Development and Use of Novel 

Alternative Methods to Advance Biomedical 

Research; Update from the ACD Working 

Group on Re-envisioning NIH-Supported 

Postdoctoral Training; Other Business of the 

Committee. 

Place: National Institutes of Health, 

Building 1, Wilson Hall, One Center Drive, 

Bethesda, MD 20892. 

Contact Person: Cyndi Burrus-Shaw, Staff 

Assistant, National Institutes of Health, 

Office of the Director, One Center Drive, 

Building 1, Room 126, Bethesda, MD 20892, 

301–496–2433, shawcy@od.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors attending a meeting on 

campus or at an off-campus federal facility 

will be asked to show one form of 

identification (for example, a governmentissued photo ID, driver’s license, or passport) 

and to state the purpose of their visit. 

Information is also available on the 

Institute’s/Center’s home page: http://

acd.od.nih.gov, where an agenda and any 

additional information for the meeting will 

be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.14, Intramural Research 

Training Award; 93.22, Clinical Research 

Loan Repayment Program for Individuals 

from Disadvantaged Backgrounds; 93.232, 

Loan Repayment Program for Research 

Generally; 93.39, Academic Research 

Enhancement Award; 93.936, NIH Acquired 

Immunodeficiency Syndrome Research Loan 

Repayment Program; 93.187, Undergraduate 

Scholarship Program for Individuals from 

Disadvantaged Backgrounds, National 

Institutes of Health, HHS) 

Dated: November 7, 2023. 

David W. Freeman, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2023–24971 Filed 11–9–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; NIAID Investigator Initiated 

Program Project Applications (P01 Clinical 

Trial Not Allowed). 

Date: December 18, 2023. 

Time: 12:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 903 South 4th Street, RML 31/3118, 

Hamilton, MT 59840 (Virtual Meeting). 

Contact Person: Kristin L. McNally, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 903 

South 4th Street, RML 31/3118, Hamilton, 

MT 59840, mcnallyk@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: November 7, 2023. 

David W. Freeman, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2023–24964 Filed 11–9–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; NIAID Investigator Initiated 

Program Project Applications (P01 Clinical 

Trial Not Allowed). 


khammond on DSKJM1Z7X2PROD with NOTICES
77596 Federal Register / Vol. 88, No. 217 / Monday, November 13, 2023 / Notices 

Date: December 15, 2023. 

Time: 10:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G42B, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Louis A. Rosenthal, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3G42B, Rockville, MD 

20852, (240) 669–5070, rosenthalla@

niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: November 7, 2023. 

David W. Freeman, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2023–24965 Filed 11–9–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Advisory 

Neurological Disorders and Stroke 

Council. 

The meeting will be partially open to 

the public as indicated below. 

Individuals who plan to participate and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be partially closed 

to the public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5, U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Neurological Disorders and Stroke Council. 

Date: February 14–15, 2024. 

Open: February 14, 2024, 10:00 a.m. to 4:00 

p.m. 

Agenda: Report by the Director, NINDS; 

Report by the Director, Division of 

Extramural Activities; and Administrative 

and Program Developments 

Open session will be videocast from this 

link: https://videocast.nih.gov/watch=52772. 

Closed: February 14, 2024, 4:00 p.m. to 

5:30 p.m. 

February 15, 2024, 9:30 a.m. to 12:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6001 

Executive Boulevard, Room 1131, Rockville, 

Maryland 20852 (Virtual Meeting). 

Contact Person: David Owens, Ph.D., 

Director of Extramural Activities (Acting), 

National Institute of Neurological Disorders 

and Stroke, NIH, 6001 Executive Blvd., 5th 

Floor, MSC 9531, Bethesda, MD 20892, (301) 

496–9248, owensd@ninds.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice at least 10 days in advance of the 

meeting. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: 

www.ninds.nih.gov, where an agenda and 

any additional information for the meeting 

will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS.) 

Dated: November 7, 2023. 

David W. Freeman, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2023–24963 Filed 11–9–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Amended Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Sickle Cell Disease 

Advisory Committee, January 29, 2024, 

10:00 a.m. to January 29, 2024, 3:00 

p.m., National Institutes of Health, 

Rockledge I, 6705 Rockledge Drive, 

Bethesda, MD 20892 which was 

published in the Federal Register on 

September 28, 2023, FR Doc 2023– 

21315, 88 FR 67324. 

This Notice is being amended to 

update the Registration Link. The event 

is free and open to the public; however, 

registration is required. Please use this 

included link to register: https://

nih.zoomgov.com/webinar/register/WN_

X-5kA5CJQG6Qmk_ujQsqAw. 

Dated: November 7, 2023. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–24962 Filed 11–9–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Mentored Patient Oriented Review. 

Date: November 17, 2023. 

Time: 1:00 p.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge I, 6705 Rockledge Drive, Bethesda, 

MD 20892 (Virtual Meeting). 

Contact Person: Fungai Chanetsa, Ph.D., 

MPH, Scientific Review Officer, Office of 

Scientific Review/DERA, National Heart, 

Lung, and Blood Institute National Institutes 

of Health, 6705 Rockledge Drive, Room 206– 

B, Bethesda, MD 20817, (301) 402–9394, 

fungai.chanetsa@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: November 7, 2023. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–24926 Filed 11–9–23; 8:45 am] 

BILLING CODE 4140–01–P 


khammond on DSKJM1Z7X2PROD with NOTICES